Novo Nordisk CEO to testify at Senate hearing over high weight loss drug prices
Sort by
663 items
-
CNBC - Business
'Stop ripping us off': Novo Nordisk CEO faces Senate grilling over weight loss drug prices
Sen. Bernie Sanders argues that Novo Nordisk charges Americans substantially higher prices for its drugs than it does for patients in other countries.19 minutes ago -
The Hill - Politics
Watch live: Senate Judiciary holds hearing on Supreme Court immunity ruling
The Senate Judiciary Committee will hold a hearing Tuesday morning focused on potential risks following the Supreme Court's unprecedented decision earlier this year that determined core ...1 hour ago -
The Hill - Politics
Watch live: Senate HELP committee grills Novo Nordisk on weight loss drug pricing
Sen. Bernie Sanders (I-Vt.), chair of the Senate Health, Education, Labor and Pensions (HELP) Committee, is set to grill Novo Nordisk CEO Lars Jorgenson Tuesday morning over prices on the ...1 hour ago -
CBS News - Top stories
CEO of company of popular weight loss drugs to face Senate questions over high costs in U.S.
Senior investigative consumer correspondent Anna Werner looked into the high prices of weight loss drugs in the U.S. as research shows Americans pay far more for some of the popular drugs compared ...1 hour ago -
MarketWatch - Business
Home prices grew at the slowest pace in 8 months, Case Shiller says, but still inch up to new record high
Case-Shiller 20-city home price index rose 5.9% year-on-year in July.1 hour ago -
CBS News - Top stories
Ozempic maker to testify before Senate committee on weight loss drug prices
Novo Nordisk CEO Lars Fruergaard Jørgensen is testifying before the Senate Health, Education, Labor and Pension committee on Tuesday.1 hour ago -
MarketWatch - Business
Novo Nordisk CEO set to defend Ozempic, Wegovy prices on Capitol Hill
The CEO of Novo Nordisk is set to face pointed questions on Capitol Hill Tuesday about the prices of the Danish pharmaceutical giant’s blockbuster drugs Ozempic and Wegovy.2 hours ago -
NBC News - Top stories
Simone Biles takes a victory lap in high-flying Gold Over America Tour
The gymnastics GOAT, with 11 Olympic medals, has kicked off her 30-city national tour.4 hours ago -
NBC News - Top stories
Maker of Ozempic and Wegovy faces grilling over high cost of weight loss drugs
Is Ozempic and Wegovy maker Novo Nordisk helping Americans save taxpayer money or ripping them off? The company's CEO is scheduled to testify on Capitol Hill Tuesday.6 hours ago -
CBS Sports - Sports
NFL Week 3 grades: Commanders earn an 'A' for upset win over Bengals, Jaguars receive an 'F' for blowout loss
Here are the Week 3 grades for every team12 hours ago - NFL -
The Hill - Politics
Novo CEO to blame drug middlemen
Presented by Prevent Cancer Foundation — The CEO of Novo Nordisk will testify in the Senate HELP Committee tomorrow about the cost of popular diabetes and weight loss drugs Ozempic and Wegovy. ...17 hours ago -
-
The Hill - Politics
Brett Favre to testify Tuesday at House welfare reform hearing amid Mississippi scandal
Brett Favre is set to testify Tuesday at a hearing of the House Ways and Means Committee examining welfare reform, the panel confirmed to The Hill, an appearance that comes after the former NFL ...Yesterday -
ESPN - Sports
Roma CEO quits amid fan fury over De Rossi axe
Roma chief executive Lina Souloukou has stepped down, the Serie A club said on Sunday, following fan anger over the sacking of manager Daniele De Rossi.Yesterday -
Financial Times - World
Novo Nordisk faces US Senate grilling over price of weight loss drugs
Senator Bernie Sanders accuses Ozempic and Wegovy maker of ‘ripping off’ AmericansYesterday -
The Hill - Politics
Over 700 high-ranking national security officials endorse Harris
Over 700 high-ranking national security officials have endorsed Democratic candidate Vice President Harris in her run for the White House, with some leaders expressing concerns about former ...2 days ago -
The Guardian - World
No promotions, no buzz. Home workers pay high price while bosses save on costs | Martha Gill
Labour’s legislation confronting a ‘culture of presenteeism’ may inadvertently favour employers and cause the badly paid to lose out. At the age of 25, casting around for what to do next, I was ...2 days ago -
CBS News - Top stories
As weight loss drugs explode in popularity, are online marketplaces safe?
Weight loss drugs are exploding in popularity, with 1 in 8 Americans saying they have tried medications like Ozempic and Wegovy to tackle everything from diabetes to weight loss, among other ...2 days ago -
CNBC - Business
FTC sues drug middlemen for allegedly inflating insulin prices
The FTC suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's Express Scripts.3 days ago -
CBS News - Top stories
Inside the thriving market for alternatives to brand-name weight loss drugs
High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the meantime, a market for cheaper, compounded drugs thrives.3 days ago -
NBC News - Top stories
Federal Trade Commission accuses three drug middlemen of inflating insulin prices
The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.3 days ago -
ABC News - Health
An appeals court has revived a challenge to President Biden's Medicare drug price reduction program
A constitutional challenge to the Biden administration program enabling Medicare to negotiate lower prices for prescription drugs has been revived by a federal appeals court3 days ago - Joe Biden -
ABC News - Health
High insulin prices spur a federal lawsuit against three pharmacy benefit managers
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for patients3 days ago -
The Hill - Politics
FTC sues three largest drug middlemen for allegedly inflating insulin prices
The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged anticompetitive practices that boosted profits while “artificially” ...3 days ago -
MarketWatch - Business
FTC sues prescription-drug middlemen over insulin prices, says drugmakers are also ‘on notice’
Pharmacy-benefit managers owned by CVS, Cigna and UnitedHealth “artificially inflated” prices for lifesaving medications, regulator alleges.3 days ago -
The New York Times - Health
F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more.3 days ago -
Financial Times - Business
US drug ‘gatekeepers’ face FTC antitrust lawsuit over insulin prices
Complaint alleges pharmacy benefit managers owned by CVS, Cigna and UnitedHealth are keeping prices high3 days ago -
The Wall Street Journal - Business
FTC Accuses Drug Middlemen of Inflating Insulin Prices
The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms of inflating the price of insulin.3 days ago -
The Wall Street Journal - Business
FTC Accuses Drug Middlemen of Inflating Insulin Prices
The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms of inflating the price of insulin.3 days ago -
NBC News - Top stories
Harris could win the presidency but lose the Senate, giving Republicans a veto over her agenda and judges
If Kamala Harris defeats Donald Trump and wins the presidency, she may still face a Republican Senate that could block her nominees and agenda.4 days ago -
Financial Times - World
FirstFT: Wall Street titan John Paulson defends Trump’s tariff talk
Also in today’s newsletter, S&P 500 hits record high and Amazon’s crackdown on remote work4 days ago -
The Wall Street Journal - Business
The Price War in Weight-Loss Drugs Is Here
Novo Nordisk and Eli Lilly are offering discounts to encourage more insurance coverage of the medicines, which carry price tags of over $1,000 a month.4 days ago -
Financial Times - World
UK government borrows more than expected in August
Net debt hits 100% of GDP in blow to chancellor Rachel Reeves ahead of Budget4 days ago - United Kingdom -
Financial Times - World
Immigration and job creation
The labour market is softer than it appears4 days ago -
Financial Times - World
Lammy seeks emergency boost to aid cash to offset cost of migrant hotels
Foreign secretary fears domestic drain on development funding will hinder efforts to project UK on global stage4 days ago